State v. Abbvie Inc.

Good Law
390 F. Supp. 3d 1176
United States District Court, Northern District of CaliforniaJuly 25, 2019Case No. 18-cv-06392-JDCalifornia3,007 words

Opinion

Lead Opinion

ORDER RE MOTION TO REMAND

JAMES DONATO, United States District Judge *1178 This case was originally filed in Alameda Superior Court, and alleges a campaign of kickbacks and other inducements by defendant AbbVie Inc. to inflate sales of its Humira drug, which is used to treat autoimmune disorders such as arthritis and colitis. See Dkt. No. 1-1. 1 The complaint is based on AbbVie's conduct in California with California patients and California healthcare providers. Plaintiffs are the State of California, by and through the California Insurance Commissioner ("Commissioner"), and relator-plaintiff Lazaro Suarez. The complaint states a single claim under the California Insurance Frauds Prevention Act, which prohibits the use of "runners, cappers, steerers, or other persons to procure clients or patients to perform or obtain services or benefits" covered by insurance. Cal. Ins. Code § 1871.7 (a) ("IFPA").

AbbVie removed the case to this Court on the argument that it has complete diversity with Suarez and that the State of California should be disregarded as a nominal party for jurisdictional purposes. Dkt. No. 1 at 2-3. Plaintiffs now ask for the matter to be remanded to state court.…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.